# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-021373
Filing Date
2022-08-05
Accepted
2022-08-05 16:23:24
Documents
69
Period of Report
2022-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | bcrx-20220630.htm iXBRL | 10-Q | 1576973
2 | EX-10.3 | exhibit103.htm | EX-10.3 | 45398
3 | EX-10.4 | exhibit104.htm | EX-10.4 | 43516
4 | EX-10.5 | exhibit10.htm | EX-10.5 | 689
5 | EX-31.1 | bcrx-20220630xexx311.htm | EX-31.1 | 9590
6 | EX-31.2 | bcrx-20220630xexx312.htm | EX-31.2 | 9564
7 | EX-32.1 | bcrx-20220630xexx321.htm | EX-32.1 | 4723
8 | EX-32.2 | bcrx-20220630xexx322.htm | EX-32.2 | 4664
14 |  | exhibit10001.jpg | GRAPHIC | 223155
| Complete submission text file | 0001628280-22-021373.txt |  | 7665566

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | bcrx-20220630.xsd | EX-101.SCH | 63013
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | bcrx-20220630_cal.xml | EX-101.CAL | 49643
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | bcrx-20220630_def.xml | EX-101.DEF | 276099
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | bcrx-20220630_lab.xml | EX-101.LAB | 664276
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | bcrx-20220630_pre.xml | EX-101.PRE | 394307
63 | EXTRACTED XBRL INSTANCE DOCUMENT | bcrx-20220630_htm.xml | XML | 1154347

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 221141179
SIC: 2836 Biological Products, (No Diagnostic Substances)